RecruitingPhase 2NCT06537999
A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor Neuropathy
Studying Multifocal motor neuropathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Dianthus Therapeutics
- Intervention
- DNTH103(drug)
- Enrollment
- 36 target
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2024 – 2028
Study locations (25)
- Clinical Study Site, Scottsdale, Arizona, United States
- Clinical Study Site, Los Angeles, California, United States
- Clinical Study Site, Bradenton, Florida, United States
- Clinical Study Site, Tampa, Florida, United States
- Clinical Study Site, Honolulu, Hawaii, United States
- Clinical Study Site, Kansas City, Kansas, United States
- Clinical Study Site, Chapel Hill, North Carolina, United States
- Clinical Study Site, Cincinnati, Ohio, United States
- Clinical Study Site, Columbus, Ohio, United States
- Clinical Study Site, Houston, Texas, United States
- Clinical Study Site, Aarhus, Denmark
- Clinical Study Site, Copenhagen, Denmark
- Clinical Study Site, Marseille, France
- Clinical Study Site, Paris, France
- Clinical Study Site, Rome, Italy
- +10 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06537999 on ClinicalTrials.govOther trials for Multifocal motor neuropathy
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT06742190A Study to Assess the Efficacy and Safety of Empasiprubart Versus IVIg in Adults With Multifocal Motor Neuropathyargenx
- ACTIVE NOT RECRUITINGNCT05988073A Prospective Longitudinal Study in Adults With Multifocal Motor Neuropathyargenx
- ACTIVE NOT RECRUITINGPHASE2NCT05405361A Clinical Trial to Investigate the Long-term Safety and Tolerability, Efficacy, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of ARGX-117 in Adults With Multifocal Motor Neuropathyargenx